Condition: Chronic Inflammatory Demyelinating Polyneuropathy · CIDP · CIDP - Chronic Inflammatory Demyelinating Polyneuropathy · Sponsor: argenx
The main purpose of this study is to compare empasiprubart and IVIg for treating people with CIDP. This study consists of a Part A where participants will either receive empasiprubart and a placebo resembling IVIg, or IVIg and a placebo resembling empasiprubart for 24 weeks (6 months). Following Part A, participants will enter Part B in which all participants will receive empasiprubart for 96 weeks (24 months). More information can be found here: https://clinicaltrials.argenx.com/emvigorate
This description comes directly from the study's public registry record.
Sabine Coppieters, MD · 857-350-4834 · clinicaltrials@argenx.com
Always discuss trial participation with your own doctor first.
| University of Alabama | Birmingham, Alabama, United States | Recruiting |
| Samir Macwan, M.D., Inc. | Rancho Mirage, California, United States | Recruiting |
| Colorado Springs Neurological Associates | Colorado Springs, Colorado, United States | Recruiting |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| Homestead Associates in Research Inc | Homestead, Florida, United States | Recruiting |
| Visionary Investigators Network | Miami, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Paradigm Health System | Slidell, Louisiana, United States | Recruiting |
| Erlanger Health System | Columbia, Maryland, United States | Recruiting |
| University of Michigan Hospital | Ann Arbor, Michigan, United States | Recruiting |
| NeuroCarePlus | Houston, Texas, United States | Recruiting |
| National Neuromuscular Research Institute | Irving, Texas, United States | Recruiting |
+ 70 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06920004